Results 131 to 140 of about 24,429,900 (206)

Pixavir Marboxil: First Approval. [PDF]

Drugs
Kang C.
europepmc   +1 more source

Design and synthesis of C-2 substituted thiazolo and dihydrothiazolo ring-fused 2-pyridones: pilicides with increased antivirulence activity. [PDF]

J Med Chem, 2010
Chorell E, Pinkner JS, Phan G, Edvinsson S, Buelens F, Remaut H, Waksman G, Hultgren SJ, Almqvist F.   +8 more
europepmc   +1 more source

Neuroimmunomodulation of AMPA Receptors Through Combination of Medium-Chain Triglycerides and Perampanel to Treat Status Epilepticus in Anti-NMDA Receptor Encephalitis. [PDF]

J Neuroimmune Pharmacol
Stadler LM, Schappe L, Lochner P, Bonifer L, Fousse M, Meuth SG, Groppa S, Winter Y.   +7 more
europepmc   +1 more source

Novel bioactive compounds from marine-derived endosymbiotic Penicillium fungi reported during 2020-2025. [PDF]

Nat Prod Bioprospect
Omran SA, Elnaggar MS, Youssef FS, El-Moghazy SA.   +3 more
europepmc   +1 more source

Brief Report: Real-World Uptake and Clinical Outcomes of Long-Acting Injectable Cabotegravir/Rilpivirine in the United States, 2021-2023. [PDF]

J Acquir Immune Defic Syndr
O'Shea J, Derton A, Henson J, Iqbal K, Briggs-Hagen M, Kourtis AP, Buchacz K.   +6 more
europepmc   +1 more source

Red cell exchange removes apixaban in patients with sickle cell disease. [PDF]

Transfusion
Boyle K, Evans M, Mansfield C, Notini M, Garrett ME, Arepally GM, Lee GM.   +6 more
europepmc   +1 more source

Precise control of selective nitrogen atom insertion into five-membered cyclic β-ketoesters. [PDF]

Nat Commun
Zhang Y, Wang J, Tao Y, Wang A, Shen G, Li Z, Zhang M, Yu B, Zhang X, Huang X.   +9 more
europepmc   +1 more source

Seminal plasma concentrations of long-acting cabotegravir in men receiving HIV pre-exposure prophylaxis. [PDF]

Antimicrob Agents Chemother
Moschese D, Fusetti C, Lazzarin S, Giacomelli A, Mazzotta V, Cattaneo D, D'Avolio A, Caruso F, Maddalena D, Petri F, Antinori A, Gervasoni C, Gori A, Cossu MV.   +13 more
europepmc   +1 more source

Switching to doravirine-based antiretroviral therapy without genotypic resistance tests in virologically suppressed people with HIV. [PDF]

AIDS
Mason J, Kohli M, Taiwo E, Maan I, Gharib Y, Suonpera E, Barlow M, Olcott F, Waters L, Arenas-Pinto A, Gilson R, Pett S.   +11 more
europepmc   +1 more source

KRAS Footprints in the Skin: Leveraging Targeted Therapy for Unresectable Intra-Cerebral AVM. [PDF]

Pediatr Dermatol
Zhang D, Kwon JM, Aagaard-Kienitz B, Rebsamen SL, Mc Dermott SE, Arkin LM.   +5 more
europepmc   +1 more source